Home > News > Show Me A Sign
September 15th, 2005
Show Me A Sign
Joe Alper: Initial clinical trials with some of these apoptosis detectors have shown promise, and now investigators are bringing the power of nanotechnology to bear on this effort in order to create powerful systems that would ultimately be capable of both delivering an anti-tumor drug and monitoring, in real time, if it is triggering cell death. The development of a nanotechnology-enabled apoptosis detector is one of the strategic areas of emphasis of the NCI Alliance for Nanotechnology in Cancer.
Though this work is still in its early stages, its potential is a harbinger of things to come. "Having a real-time apoptosis detector would represent a significant advance in cancer therapy, one that would let us alter treatment to reflect how each patient responds to a given set of drugs soon after being given those drugs," remarked James Olson, M.D.
Nanotech Coatings UK Limited Announces Plans to Launch Industrial Nanotech, Inc.ís Next Generation Roofing Product to UK & Ireland Markets in Early 2014 December 16th, 2013
Conference speakers: International think tank needed to identify techno-social turning points December 6th, 2013
Bangalore INDIA NANO 2013 Inaugurated December 5th, 2013
3-D printing and custom manufacturing: from concept to classroom: Strategic investments from NSF help engineers revolutionize the manufacturing process December 5th, 2013
DNA clamp to grab cancer before it develops December 20th, 2013
New mechanism that permits selective capture of microRNAs in nanovesicles that shuttle between cells: The study presents the first description of a set of related nuceleotide sequences essential for the role of these small molecules in intercellular communication December 20th, 2013
UCLA researcher highlights advances in nanotechnology's fight against cancer December 19th, 2013
Arrowhead Reports Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Today at 4:30 p.m Eastern Time December 18th, 2013